Brain+ presents at the 5[th] Annual DTx (Digital Therapeutics) Europe conference
Copenhagen, Denmark, June 27, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“BRAINP”) today informed that the company has been invited to participate at the 5[th ]Annual DTx Europe conference to be held in London on June 28[-]29[th]. At the conference, CEO Kim Baden-Kristensen will present a Brain+ case study on ‘Managing the Need for Evidence in a DTx Start-up’, scheduled for June 28[th] at 2:10 p.m. BST (3:10 p.m. CET) and speak on a Keynote Panel Discussion on the topic of ’Is the Clinic Ready for DTx?’, on June 29[th] at 9:00 a.m. BST (10:00 a.m. CET).The DTx Europe